Sharechat Logo

Tower retains right to sell policies to ANZ National clients

Friday 13th March 2009

Text too small?
Tower has retained the right to sell insurance to customers of ANZ National Bank and ING (NZ) after the lender sought a court ruling to prevent policies being renewed while it lined up a rival underwriter, Vero Insurance.

The High Court rejected a claim from ANZ and ING, according to a statement from Tower managing director Rob Flannagan. Tower was entitled to renew policies with the bank's customers even after the firm's policy agreement had ended, he said, citing a ruling from Justice Wylie.

The judgment said the bank's customers became Tower's clients as well when they were sold Tower policies. It was "somewhat arrogant for the bank to now try to interfere with that contractual relationship simply because it allowed the policies to be sold with its brands on them," according to the statement.

At stake is ownership of some 196,000 policies, held by 110,000 policyholders.

ANZ National also sought orders requiring Tower to hand over policy information to the bank so it could pass the details to Vero. Justice Wylie ruled that ANZ National was entitled to receive the information but Tower couldn't hand it over with the consent of the customers. ANZ National was prohibited from handing the data to Vero, the statement said.

A hearing has yet to be fixed for a counterclaim from Tower.
Shares of Tower fell 3% to $1.30 and are down 12% this year.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy